Skip to main content
Fig. 8 | Lipids in Health and Disease

Fig. 8

From: WY-14643 attenuates lipid deposition via activation of the PPARα/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in ccRCC

Fig. 8

WY-14,643 inhibits the NF-κB pathway. a and b. After different doses of WY-14,643 were applied, apoptosis-related proteins were evaluated and analyzed quantitatively in ccRCC cells (n = 3). c and d. Bax/Bcl-2 was calculated in ccRCC cells. e and f. After specified doses of WY-14,643 were administered, the NF-κB pathway were measured by western blotting and analyzed quantitatively (n = 3). *P < 0.05, **P < 0.01. WY, WY-14,643

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X